Pages that link to "Q39321109"
Jump to navigation
Jump to search
The following pages link to Targeting HSP90 by the novel inhibitor NVP-AUY922 reduces growth and angiogenesis of pancreatic cancer. (Q39321109):
Displaying 16 items.
- Comparative Study of 17-AAG and NVP-AUY922 in Pancreatic and Colorectal Cancer Cells: Are There Common Determinants of Sensitivity? (Q34478388) (← links)
- Role of the novel HSP90 inhibitor AUY922 in hepatocellular carcinoma: Potential for therapy (Q35726863) (← links)
- Molecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancer. (Q37092020) (← links)
- Radiosensitizers in pancreatic cancer--preclinical and clinical exploits with molecularly targeted agents. (Q37403232) (← links)
- Sulphoxythiocarbamates modify cysteine residues in HSP90 causing degradation of client proteins and inhibition of cancer cell proliferation. (Q37459656) (← links)
- Contributions of co-chaperones and post-translational modifications towards Hsp90 drug sensitivity (Q38111801) (← links)
- Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales (Q38130312) (← links)
- Effects of the novel heat shock protein 90 inhibitor AUY922 in renal cell carcinoma ACHN and 786-O cells (Q38815491) (← links)
- Destabilizing RET in targeted treatment of thyroid cancers (Q38819099) (← links)
- Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancer (Q38982959) (← links)
- Potent antitumor activity of HSP90 inhibitor AUY922 in adrenocortical carcinoma (Q38992870) (← links)
- Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells. (Q39203018) (← links)
- Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion (Q48121004) (← links)
- Tigecycline as a dual inhibitor of retinoblastoma and angiogenesis via inducing mitochondrial dysfunctions and oxidative damage (Q58799509) (← links)
- Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage (Q92191529) (← links)
- HSP90 Molecular Chaperones, Metabolic Rewiring, and Epigenetics: Impact on Tumor Progression and Perspective for Anticancer Therapy (Q92519795) (← links)